Moxifloxacin Pharmacokinetics/Pharmacodynamics and Optimal Dose and Susceptibility Breakpoint Identification for Treatment of Disseminated Mycobacterium avium Infection

Organisms of the Mycobacterium avium-intracellulare complex (MAC) have been demonstrated to be susceptible to moxifloxacin. However, clinical data on how to utilize moxifloxacin to treat disseminated MAC are scanty. In addition, there have been no moxifloxacin pharmacokinetic-pharmacodynamic (PK/PD)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Deshpande, Devyani, Srivastava, Shashikant, Meek, Claudia, Leff, Richard, Hall, Gerri S., Gumbo, Tawanda
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2010
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2876403/
https://ncbi.nlm.nih.gov/pubmed/20385862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01761-09
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados